The Trustees of the University of Pennsylvania;Steven M. Albelda;Novartis AG
发明人:
Steven M. ALBELDA
申请号:
US15568683
公开号:
US20180298068A1
申请日:
2016.04.22
申请国别(地区):
US
年份:
2018
代理人:
摘要:
The invention provides compositions and methods for treating diseases associated with expression of a cancer associated antigen as described herein. The invention also relates to chimeric antigen receptor (CAR) specific to a cancer associated antigen as described herein, vectors encoding the same, and recombinant T cells comprising the CARs of the present invention. The invention also includes methods of administering a genetically modified T cell expressing a CAR that comprises an antigen binding domain that binds to a cancer associated antigen as described herein.